Repository logo
 
Publication

Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024

2024-08-15Journal article Open access
Simple item page
dc.contributor.authorAntunes, Liliana
dc.contributor.authorMazagatos, Clara
dc.contributor.authorMartínez‐Baz, Iván
dc.contributor.authorNaesens, Reinout
dc.contributor.authorBorg, Maria‐Louise
dc.contributor.authorPetrović, Goranka
dc.contributor.authorFatukasi, Terra
dc.contributor.authorJancoriene, Ligita
dc.contributor.authorMachado, Ausenda
dc.contributor.authorOroszi, Beatrix
dc.contributor.authorHusa, Petr
dc.contributor.authorLazar, Mihaela
dc.contributor.authorDürrwald, Ralf
dc.contributor.authorHoward, Jennifer
dc.contributor.authorMelo, Aryse
dc.contributor.authorPérez‐Gimeno, Gloria
dc.contributor.authorCastilla, Jesús
dc.contributor.authorBernaert, Eva
dc.contributor.authorDžiugytė, Aušra
dc.contributor.authorMakarić, Zvjezdana Lovrić
dc.contributor.authorFitzgerald, Margaret
dc.contributor.authorMickienė, Auksė
dc.contributor.authorGómez, Verónica
dc.contributor.authorTúri, Gergő
dc.contributor.authorSoučková, Lenka
dc.contributor.authorMarin, Alexandru
dc.contributor.authorTolksdorf, Kristin
dc.contributor.authorNicolay, Nathalie
dc.contributor.authorRose, Angela M.C.
dc.contributor.authorEuropean Hospital Vaccine Effectiveness Group
dc.date.accessioned2025-03-06T14:17:13Z
dc.date.available2025-03-06T14:17:13Z
dc.date.issued2024-08-15
dc.description.abstractWe conducted a multicentre test-negative case–control study covering the period from October 2023 to January 2024 among adult patients aged ≥18 years hospitalised with severe acute respiratory infection in Europe. We provide early estimates of the effectiveness of the newly adapted XBB.1.5 COVID-19 vaccines against PCR-confirmed SARS-CoV-2 hospitalisation. Vaccine effectiveness was 49% overall, ranging between 69% at 14–29days and 40% at 60–105days post vaccination. The adapted XBB.1.5 COVID-19 vaccines conferred protection against COVID-19 hospitalisation in the first 3.5months post vaccination, with VE>70% in older adults (≥65 years) up to 1month post vaccination.pt_PT
dc.description.sponsorshipThe ‘Vaccine Effectiveness, Burden and Impact Studies’ (VEBIS) is a project of the European Centre for Disease Prevention and Control (ECDC) run under the framework contract No. ECDC/2021/016.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationInfluenza Other Respir Viruses. 2024 Aug;18(8):e13360. doi: 10.1111/irv.13360.
dc.identifier.doi10.1111/irv.13360pt_PT
dc.identifier.issn1750-2640
dc.identifier.urihttp://hdl.handle.net/10400.18/10418
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherWiley
dc.relationECDC/2021/016pt_PT
dc.relation.hasversionhttps://onlinelibrary.wiley.com/doi/10.1111/irv.13360
dc.relation.publisherversionhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11325250/pdf/IRV-18-e13360.pdfpt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectCOVID-19 XBB.1.5pt_PT
dc.subjectSARS‐CoV‐2 Hospitalisation
dc.subjectVaccinept_PT
dc.subjectVaccine Effectiveness
dc.subjectEurope
dc.subjectEstados de Saúde e de Doençapt_PT
dc.subjectInvestigação em Serviços de Saúdept_PT
dc.subjectInfecções Respiratórias
dc.titleEarly COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024eng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue8pt_PT
oaire.citation.startPagee13360
oaire.citation.titleInfluenza and Other Respiratory Viruses
oaire.citation.volume18pt_PT
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNamedo Carmo Cerdeira Antunes
person.familyNameMachado
person.familyNameGOMEZ TEIXEIRA PINTO
person.givenNameLiliana
person.givenNameAusenda
person.givenNameVERÓNICA DEL PILAR
person.identifier.ciencia-idE51A-FB28-9B01
person.identifier.ciencia-id1217-6076-5D88
person.identifier.ciencia-idFA1B-D68F-2611
person.identifier.orcid0000-0003-0453-5304
person.identifier.orcid0000-0002-1849-1499
person.identifier.orcid0000-0003-0485-0005
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication3241060c-e155-4c58-9c68-a6afba0e48be
relation.isAuthorOfPublication544ad266-0c22-4a50-9ebc-86acc08d6666
relation.isAuthorOfPublicationeae04cda-2c73-437b-8666-6593d03aa34d
relation.isAuthorOfPublication.latestForDiscovery3241060c-e155-4c58-9c68-a6afba0e48be

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IRV-18-e13360.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

DEP - Artigos em revistas internacionais
DDI - Artigos em revistas internacionais
INSA - Artigos em revistas internacionais